GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vapotherm Inc (FRA:VA20) » Definitions » Institutional Ownership

Vapotherm (FRA:VA20) Institutional Ownership : 5.83% (As of May. 28, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Vapotherm Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Vapotherm's institutional ownership is 5.83%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Vapotherm's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Vapotherm's Float Percentage Of Total Shares Outstanding is 75.38%.


Vapotherm Institutional Ownership Historical Data

The historical data trend for Vapotherm's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vapotherm Institutional Ownership Chart

Vapotherm Historical Data

The historical data trend for Vapotherm can be seen below:

2023-04-30 2023-05-31 2023-06-30 2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31
Institutional Ownership 11.96 11.71 12.29 12.25 12.42 12.40 10.53 10.53 5.83 5.83

Vapotherm Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Vapotherm (FRA:VA20) Business Description

Traded in Other Exchanges
Address
100 Domain Drive, Exeter, NH, USA, 03833
Vapotherm Inc is a medical technology company based in the United States. It is mainly engaged in the development and commercialization of its proprietary Hi-VNI technology products that are used to treat patients of all ages suffering from respiratory distress. The company offers four versions of its Precision Flow systems: Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox. It generates revenue primarily from sales of proprietary Precision Flow systems to hospitals through a direct sales organization in the United States and distributors in select countries outside of the United States.

Vapotherm (FRA:VA20) Headlines

No Headlines